DataMEDS AI, Inc. Stock

MEDS

US9495032057

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 07:00:00 30/10/26 am AEDT			5-day change	1st Jan Change
2.030 ^USD	-7.73%		-25.37%	-89.84%

23/10	Datavault AI Inc. signed a letter of intent to acquire 19.90% stake in DataMEDS AI, Inc..	CI
15/10	Datameds Si Licenses U.S. Rights To Reboot Health AI's Direct-To-Consumer GLP-1 Weight Management Platform	CI

Latest news: DataMEDS AI, Inc.

23/10	Datavault AI Inc. signed a letter of intent to acquire 19.90% stake in DataMEDS AI, Inc..	CI
15/10	Datameds Si Licenses U.S. Rights To Reboot Health AI's Direct-To-Consumer GLP-1 Weight Management Platform	CI
13/10	Exchange-Traded Funds Lower, Equity Futures Mixed Pre-Bell Monday as Investors Weigh Oil, Earnings	MT
12/10	Top Premarket Gainers	MT
12/10	DataMeds AI Says Helomics' ChemoFx Test Receives Humana Medicaid Coverage Policy; Shares Rise Pre-Bell	MT
01/10	Top Premarket Gainers	MT
29/09	US Equity Indexes Fall as Iran Talks Stall, Fed Governor Points to Higher Rates, Inflation	MT
29/09	Top Midday Gainers	MT
17/09	Top Midday Gainers	MT
16/09	Axe Compute Sells AI Cancer Diagnostics Unit to DataMEDS AI	MT
15/09	DataMEDS AI, Inc. acquired Helomics Corporation from Axe Compute Inc. for $1.5 million.	CI
17/08	DataMEDS AI, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
22/07	DataMEDS AI, Inc. will Change its Ticker to MEDS from WGRX	CI

More news

Press Releases: DataMEDS AI, Inc.

12/10	DataMEDS AI : SI Announces Helomics Receives Medicaid Coverage Policy For Chemofx Assay In Gynecologic Cancers	PU
05/10	Datameds AI Files DBAs Datameds SI And Corexa Health SI And Reminds Shareholders Of Record As Of August 7, 2026 Of Dream Bowl Meme Coin I Payment	AQ
02/10	DarkHorse CEO Details AI Infrastructure Strategy as DRK Targets Sub-50 MW Compute Opportunity	AQ
01/10	DataMeds AI's Corexa Pharmacy Surpasses $1 Million In Monthly Revenue	AQ
28/09	DataMeds AI and Tollo Health Announce Launch of 'Health Lives Here' Mobile Application	AQ

More press releases

Managers and Directors: DataMEDS AI, Inc.

Manager	Title	Age	Since
Gerald Commissiong CEO	Chief Executive Officer	44	20/05/2026
Prashant Patel CEO	Chief Executive Officer	52	03/10/2025
Eric Sherb DFI	Director of Finance/CFO	40	07/10/2025

Director	Title	Age	Since
Surendra Ajjarapu CHM	Chairman	55	06/09/2022
Donald Fell BRD	Director/Board Member	80	02/10/2025
Prashant Patel BRD	Director/Board Member	52	02/10/2025

More insiders

Medical Software & Technology Services

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
DATAMEDS AI, INC.	-7.73%	-25.37%	-93.75%	-	6.74M
THERMO FISHER SCIENTIFIC, INC.	+0.71%	+2.18%	+27.18%	+64.39%	260B
DANAHER CORPORATION	+1.24%	+1.33%	+9.26%	+26.13%	165B
INTUITIVE SURGICAL, INC.	+1.03%	+4.82%	-17.72%	+73.28%	154B
BOSTON SCIENTIFIC CORPORATION	+0.61%	-4.09%	-57.72%	-13.79%	61.49B
EDWARDS LIFESCIENCES CORPORATION	+2.90%	+6.83%	+14.90%	+53.04%	52.9B
SIEMENS HEALTHINEERS AG	+0.70%	+2.83%	-12.22%	-6.48%	52.84B
VEEVA SYSTEMS INC.	-2.35%	-3.19%	+6.52%	+63.75%	51.46B
AGILENT TECHNOLOGIES, INC.	-0.18%	+1.91%	+24.20%	+76.27%	51.16B
WATERS CORPORATION	+0.67%	+4.94%	+38.77%	+96.14%	46.85B
Average	-0.32%	-0.71%	-6.06%	+48.08%	89.57B
Weighted average by Cap.	+0.57%	+1.41%	+6.54%	+50.97%

See all sector performances

DataMeds AI, Inc., formerly Wellgistics Health, Inc., is a holding company. It is engaged in health information technology (IT) that focuses on the vertical integration of technology, pharmacy, pharmaceutical-adjacent and telemedicine business units. The Company conducts its business through two wholly owned subsidiaries, Wood Sage, LLC and Wellgistics LLC, and two indirect subsidiaries, Alliance Pharma Solutions, LLC and Community Specialty Pharmacy, LLC. It is focused on improving the lives of patients while delivering solutions for pharmacies, providers, pharmaceutical manufacturers, and payors. Its technology platform, DelivMeds, serves as a pharmacy hub and allows clinical services to be connected to its health pharmacy operations. This platform will allow for an end-to-end mobile application solution whereby patients can digitize their prescription journey. The solution helps to preserve patient autonomy, prescription price transparency, and provide additional concierge services.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Quotes

Date	Price	Change	Volume
30/10/26	USD 2.030	-7.73%	221,481
28/10/26	USD 2.200	+6.80%	347,469
27/10/26	USD 2.060	-5.94%	360,323
26/10/26	USD 2.190	-1.79%	617,523
23/10/26	USD 2.230	-3.04%	376,469

Delayed Quote Nasdaq

More quotes

Market Cap	6.74M 6.03M 5.57M 5.04M 9.42M 641M 9.57M 66.41M 26.49M 336M 25.28M 24.74M 1.06B	P/E 2024 *	-	P/E 2025	-0.28x
Enterprise Value	31.28M 28.02M 25.85M 23.39M 43.74M 2.98B 44.44M 308M 123M 1.56B 117M 115M 4.94B	EV / Sales 2024 *	-	EV / Sales 2025	2,769,122x
Free-Float	55.37%	Yield 2024 *	-	Yield 2025	-

1 day	-7.73%
1 week	-25.37%
Current month	-35.96%
1 month	-46.72%
3 months	-42.82%
6 months	-64.70%
Current year	-89.84%

1 week	1.97	2.37
1 month	1.97	4.35
Current year	0.82	22.5
1 year	0.82	40.85
3 years	0.82	352
5 years	0.82	352
10 years	0.82	352

Date	Insider	Type	Main position	Quantity	% Market Cap.
22/6/26	Prashant Patel	Option	Chief Executive Officer	200,000	7.9573%
31/3/26	Surendra Ajjarapu	Free	Founder	10,000,000	11.1446%
31/3/26	Prashant Patel	Free	Chief Executive Officer	10,000,000	11.1446%

	2024	2025
Net sales	18.13 16.24 14.98 13.56 25.35 1.73K 25.76 178.72 71.3 903.5 68.04 66.59 2.86K	23.34 20.9 19.29 17.45 32.63 2.22K 33.16 230.08 91.79 1.16K 87.58 85.72 3.68K
Net income	-6.86M -6.14M -5.67M -5.13M -9.59M -653M -9.74M -67.59M -26.97M -342M -25.73M -25.18M -1.08B	-101M -90.71M -83.69M -75.73M -142M -9.64B -144M -998M -398M -5.05B -380M -372M -15.99B
Net Debt	23.97M 21.47M 19.81M 17.92M 33.52M 2.28B 34.06M 236M 94.28M 1.19B 89.96M 88.04M 3.78B	24.54M 21.98M 20.28M 18.35M 34.32M 2.34B 34.87M 242M 96.52M 1.22B 92.1M 90.14M 3.87B

DataMEDS AI, Inc. Stock

Stocks

MEDS

US9495032057

Advanced Medical Equipment & Technology

Valuation: DataMEDS AI, Inc.

Chart: DataMEDS AI, Inc.

Latest news: DataMEDS AI, Inc.

Press Releases: DataMEDS AI, Inc.

Quotes and Performance

Price Extremes

Managers and Directors: DataMEDS AI, Inc.

Latest insider transactions

Medical Software & Technology Services

Financials

Company Profile

Quotes

Markets		Quality
Nasdaq	MEDS	Delayed
CBOE	MEDS	Real-time